Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz250.038
Abstract: Abstract Background Retreatment with PLD in ROC has raised potential concerns of increased toxicity and diminished response rates. This subgroup analysis examined the safety and efficacy of platinum-sensitive patients (pts) with prior PLD therapy who… read more here.
Keywords: honoraria institution; institution advisory; pld; advisory consultancy ... See more keywords
Accuracy of pathologic evaluation for thymic epithelial tumors in an Italian reference centre
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz266.014
Abstract: Abstract Background Thymic Epithelial Tumors (TETs) are rare entities, which can be diagnostic challenges for Pathologists. It has been proven that patients’ referral to a Center with an expert Pathologist is a key factor in… read more here.
Keywords: self honoraria; honoraria institution; institution advisory; institution ... See more keywords
Patient reported outcomes during immunotherapy: Symptom burden in daily clinical practice
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz276.004
Abstract: Abstract Background PD(L)1-inhibitors can cause immune-related adverse events (irAEs.). IrAEs may be under-recognized and their influence on health-related quality of life (HRQL) underestimated. At this point, insight into patient-reported symptom prevalence and intensity is limited.… read more here.
Keywords: honoraria institution; institution advisory; advisory consultancy; patient reported ... See more keywords